MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) Institutional Ownership

CUSIP: 55279B202

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2023

Type / Class
Equity / Common Stock, $0.00000002 par value
Symbol
MEIP on Nasdaq
Shares outstanding
29,545,622
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 55279B202?
CUSIP 55279B202 identifies MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Anson Funds Management LP 3.7% 1,093,188 Anson Funds Management LP 22 Jul 2025

Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$958,000 0
2023 Q2 145,654 $958,000 -$28,712,302 $6.58 1
2023 Q1 48,845,759 $11,179,346 -$295,320 $0.23 45
2022 Q4 49,485,704 $12,052,989 -$1,007,880 $0.24 45
2022 Q3 47,607,776 $18,402,998 -$90,868 $0.39 55
2022 Q2 47,449,879 $28,704,093 -$5,095,402 $0.60 59
2022 Q1 56,055,550 $33,769,440 -$85,348,603 $0.60 85
2021 Q4 89,185,933 $238,011,275 +$60,987,652 $2.67 104
2021 Q3 65,176,813 $179,904,137 -$10,864,219 $2.76 100
2021 Q2 68,991,345 $196,726,475 -$5,446,204 $2.85 105
2021 Q1 70,784,540 $242,767,740 +$18,669,651 $3.43 105
2020 Q4 65,458,547 $172,902,331 -$2,754,748 $2.64 106
2020 Q3 66,088,757 $206,202,307 +$7,178,715 $3.12 100
2020 Q2 62,875,358 $259,680,491 +$1,477,050 $4.13 100
2020 Q1 64,570,596 $103,561,509 +$22,397,311 $1.61 77
2019 Q4 49,354,861 $122,400,810 +$24,179,217 $2.48 76
2019 Q3 36,909,319 $62,006,463 -$21,615,455 $1.68 69
2019 Q2 45,960,278 $114,897,440 +$11,724,666 $2.50 70
2019 Q1 41,010,769 $125,904,000 +$2,372,403 $3.07 62
2018 Q4 40,029,928 $105,434,000 +$7,721,183 $2.64 55
2018 Q3 36,164,953 $155,872,000 -$1,323,234 $4.31 59
2018 Q2 36,391,138 $143,378,000 +$111,542,358 $3.94 57
2018 Q1 8,504,579 $17,606,115 -$506,425 $2.07 42
2017 Q4 8,747,898 $18,344,388 -$186,571 $2.10 47
2017 Q3 8,638,250 $23,161,366 +$5,784,349 $2.68 53
2017 Q2 6,647,146 $15,883,000 +$1,199,231 $2.39 44
2017 Q1 6,302,427 $10,208,000 +$579,181 $1.62 42
2016 Q4 6,477,857 $9,326,000 +$440,611 $1.44 33
2016 Q3 5,522,709 $9,719,000 -$2,415,654 $1.76 36
2016 Q2 7,628,992 $10,371,000 -$3,091,435 $1.36 33
2016 Q1 9,938,127 $12,522,000 +$584,155 $1.26 36
2015 Q4 6,600,579 $10,561,000 +$592,477 $1.60 37
2015 Q3 6,217,539 $9,759,657 +$1,986,306 $1.57 33
2015 Q2 4,929,037 $8,428,000 -$5,402,971 $1.71 37
2015 Q1 7,979,253 $14,284,000 -$53,086,251 $1.79 41
2014 Q4 22,695,018 $96,926,463 +$35,679,904 $4.27 50
2014 Q3 12,032,981 $83,027,000 -$3,244,730 $6.90 33
2014 Q2 13,292,012 $84,269,801 -$19,517,998 $6.34 40
2014 Q1 13,970,941 $155,500,299 +$18,575,595 $11.13 48